On February 1, AstraZeneca signed a cooperation agreement to provide 30 million doses of Covid-19 vaccine to the VNVC Vaccination Center of Vietnam, in the first half of 2021.
Deputy Health Minister Truong Quoc Cuong today officially approved the vaccine AstraZeneca / Oxford, for the urgent need in disease prevention.
Mr. Ngo Chi Dung, Chairman of the Board of Directors, General Director of Vietnam Vaccine Joint Stock Company (VNVC), said that the specific time of vaccine distribution to Vietnam is unknown.
“There is not yet a specific price set for the vaccine,” Dung said, but said the vaccine price is expected to “be very preferential” so that more people can be used. Information on vaccination implementation plans is being developed, under the direction and guidance of the Government and the Ministry of Health.
This is the first Covid-19 vaccine licensed by the Ministry of Health for circulation in Vietnam, with a standard two-dose injection regimen for adults aged 18 years and over.
AstraZeneca’s Covid-19 vaccine was developed with a partnership at Oxford University and with the Vaccitech manufacturing company. The vaccine uses a transcriptional vector technology created from a common strain of influenza virus in a weakened chimpanzee, containing the genetic material of the prickly protein on the nCoV surface. After the vaccination, a surface prickly protein is produced, which activates the immune system to attack nCoV if the body becomes infected with a virus.
Drug firm AstraZeneca said no major vaccine-related incidents had been reported. The preventive effect ranges from 62-90%, depending on the dose given. There were two different vaccine regimens in the trial. In the first regimen, volunteers receive half the dose, then at least a month are injected with the full dose, reaching 90% efficiency. The second regimen injected two full doses one month apart, achieving 62% efficiency. The average efficacy of the two regimens was 70%.
AstraZeneca / Oxford vaccine prices are the cheapest of the Covid-19 vaccines developed by the US or Europe, at $ 3-4 per injection. The vaccine is stored, transported and handled under normal cold storage conditions, around 2-8 ° C for at least six months, and is easily used under the conditions of today’s medical facilities.
VNVC currently has a system of nearly 50 vaccination centers, more than 50 stores of GSP standards nationwide, a distribution system, a staff of nearly 5,000 doctors, nurses, and staff, ready to receive the number. large vaccines and vaccinated millions of people, according to Mr. Dung.
At the Government’s regular meeting on January 29, Health Minister Nguyen Thanh Long said the Ministry of Health is continuing to negotiate with Pfizer, Moderna and some other vaccine manufacturers to have more vaccines.
For domestic vaccines, the Ministry of Health requires units to urgently research, clinical trials and produce vaccines to serve the people soon. The Nanocovax vaccine produced by Nanogen Company has completed phase one clinical trial and will continue with phase two in February.
The Covivax vaccine from the Nha Trang Institute of Medical Biology and Vaccines (IVAC) has begun recruiting volunteers for phase one testing, which is expected to end in late February to continue its second phase in March.
At the Government meeting on January 31, Prime Minister Nguyen Xuan Phuc requested the Ministry of Health and Deputy Prime Minister Vu Duc Dam (Head of the National Steering Committee for Covid-19 epidemic prevention) to soon submit production plans and buy vaccine for the first quarter of 2021. “The spirit is to spend the State budget and socialize resources,” the Prime Minister said.